It has been convincingly shown that the increased content of circulating SHBG has a protective value for the development of the disease; however, these relationships (their presence and orientation) may depend on the pre/postmenopausal status of women and the molecular subtype of the tumor [13,14,24,44,45]. Here, SHBG is linked to neoplasm.